Cryolife
NYSE: AORTKennesaw, US · Delaware corporation
CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.
Founders & leadership
JP
J Patrick MackinExecutive
SB
Scott B CappsExecutive
DC
David C GaleExecutive
AD
Amy D HortonExecutive
JF
Jean F HollowayExecutive
Board
TF
Thomas F AckermanBoard director
RC
Ronald C ElkinsBoard director
DJ
Daniel J BevevinoBoard director
JW
Jon W SalvesonBoard director
JS
James S BensonBoard director
RD
Ronald D McCallBoard director
HM
Harvey MorganBoard director
Reported raises · per SEC filings
Form D private placements$59M disclosed across 2 rounds · 2016–2020
▶$20MraisedSep 2020 · 27 investors · Other Health CareRule 506(b)
▶$20MraisedSep 2020 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Amy HortonExecutive Officer
- J. Patrick MackinExecutive Officer, Director
- Scott B. CappsExecutive Officer
- Jon W. SalvesonDirector
- Dennis B. MaierExecutive Officer
- Jean F HollowayExecutive Officer
- James W. BullockDirector
- D. Ashley LeeExecutive Officer
- John E. DavisExecutive Officer
- Daniel J. BevevinoDirector
- Thomas F AckermanDirector
- Jeffrey H. BurbankDirector
- Marna P. BorgstromDirector
- Michael S. SimpsonExecutive Officer
- Harvey MorganDirector
- Matthew A. GetzExecutive Officer
- Franz Peter BartholdExecutive Officer
- Ronald D. McCallDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Sep 2020
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$39MraisedJan 2016 · 8 investors · Other Health CareRule 506(b)
▶$39MraisedJan 2016 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas F AckermanDirector
- J Patrick MackinExecutive Officer, Director
- Ronald C ElkinsDirector
- Daniel J BevevinoDirector
- Scott B CappsExecutive Officer
- Jon W SalvesonDirector
- David C GaleExecutive Officer
- Amy D HortonExecutive Officer
- Jean F HollowayExecutive Officer
- James S BensonDirector
- Ronald D McCallDirector
- Harvey MorganDirector
- John E DavisExecutive Officer
- D Ashley LeeExecutive Officer
- William R MatthewsExecutive Officer
- Offering amount
- $39M
- Amount sold
- $39M
- First sale
- Jan 2016
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Rf Surgical25 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Medscape19 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Edwards Lifesciences19 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Companies competing with Cryolife for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cryolife do?
- CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.
- How much funding has Cryolife raised?
- Cryolife has disclosed $59M raised across 2 rounds.
- Where is Cryolife headquartered?
- Cryolife is headquartered in Kennesaw, US.